 |
| |
|
|
| |
|
Cummings
Properties
Over
the years Cummings Properties has developed impressive in-house expertise
in leasing, designing, and constructing biotech, pharmaceutical, and medical
facilities of all sorts. These facilities have ranged from emerging research
laboratories, to pharmaceutical pilot plants, to cGMP medical manufacturing
clean rooms. They also include hospital operating rooms and our Emerging
Tech Centers.
Cummings
Properties has built out and leased more than 2 million square feet of
Massachusetts biotech space in its ten suburban communities, as more and
more firms look especially toward the northern suburbs. A ranking of
the 100 largest biotech firms in Massachusetts, by the Boston Business
Journal, showed
more of these firms in Cummings Properties' buildings than in any
other community other than Boston or Cambridge.
Lease
genomics space, proteomics space or nanotechnology space in Massachusetts
from New England's most experienced provider. Tech space for lease from
300 to 50,000 square foot units. Lease Boston, Cambridge area space for
fuel cell technology and all other tech space needs. The firm also participates
in business and academic collaborations in Cummings Research Park. Visit
this largest provider of biotech space at Biotech 2007.
Cummings
Properties currently provides facilities for about 100 companies in the
life-sciences field, including more than 50 physicians, surgeons and dentists.
With very strong vertical integration, it can, and typically does, bring
new facilities from concept to completion in half the time taken by most
other providers. Many units are available in Energy Star buildings.
Mission
critical requirements
Cummings
Properties and many of its staff have extraordinary experience in complex
buildouts for a wide variety of high tech, biotech, and meditech facilities.
These facilities include everything from a 20,000 square foot surgi-center
with five operating rooms, to Class 100 clean rooms and BL 1, 2, and 3
labs. Others include a radio station, a television studio for SportsChannel,
and a classified "tempest room" for a major national defense
contractor, as well as the backup emergency trading floor of a major stock
exchange.
Cummings
Properties, or its own open-shop construction affiliate, Atlantic Boston
Construction, Inc., also of Woburn MA, routinely completes these projects
in remarkably short order. More than anything else, the firm expedites
projects like very few developers are likely to do, because so much of
its work can be done "immediately" by its own 280-person, full-time
staff.
Cummings
Properties links its construction performance to your lease. This single
source responsibility can save its clients significant project management
time and guarantees your project completion date. This integrated approach
similarly avoids the delays and finger-pointing that can result from traditional
multi-headed construction teams. Established relationships between all
facets of our design and construction teams speed communication and aid
in developing trust and creative solutions.
Cummings
Properties also provides for short-term, special projects to solve unanticipated
needs. This hyper-track approach yields proven delivery-speed advantages,
helping your firm keep pace with technology's rapid advances. While our
construction speed is impressive, take advantage of Cummings Properties'
wide selection of available temporary space. Office and general R&D
facilities are immediately available and can be arranged for temporary
occupancy. Even specialized technical facilities: our pre-built laboratory
incubator facilities (Emerging
Technology Centers, click here)
can provide immediate access to technical lab facilities until your main
facility is built.
Both
Cummings Park in Woburn and Cummings Center in Beverly, MA provide easy
access to Logan International Airport. Bedford's Hanscom Field is within
easy reach of Cummings Park, while Beverly Airport serves Cummings Center
with excellent private aircraft landing facilities. Helicopter landing
areas are also readily available near each of these suburban Boston office
and research parks, near Interstate 93 and Route 128.
Following
are a number of excerpts from prominent high tech and biotech firms which
currently lease office, research and laboratory space in Massachusetts
from Cummings Properties. All of these quotes are from real estate advertisements
published in The Boston Globe or Boston Business Journal.
|
|
 |
|
Aegis
Semiconductor, Inc. |
|
|
We
are delighted to be leasing from Cummings Properties. From
simplified leasing
and financing to incomparable design, construction and maintenance
services, Cummings provides it all
Theyre an excellent
collaborator for any business.
Matthias
Wagner
CEO
|
|
| Aegis
Semiconductor is an emerging leader in dynamic optical components
for communications, sensors and imaging applications. Based
on its Active Thin FilmsTM technology platform, Aegis is the
first company to deliver low-cost tunable filters that are reliable
and easily manufactured using well-tested methods from the semiconductor
industry. |
|
|
|
 |
|
Anika
Therapeutics,
Inc.
|
|
|
During
our 20-plus years in West Cummings Park, our facility and
service needs have changed considerably. Cummings Properties
has always excelled in finding solutions to meet our requirements.
We have unwavering confidence in their ability to meet our
facility needs.
Charles Sherwood, Ph.D.
President and CEO
|
|
| Anika
Therapeutics, Inc. (NASDAQ:ANIK) develops and manufactures therapeutic
products to promote the repair, protection and healing of bone,
cartilage and soft tissue. These ophthalmic and osteoarthritis
products are based on a naturally occurring, biocompatible polymer
that enhances joint function and protects soft tissues. New
product development efforts include novel HA-formulations to
reduce scar tissue formation after surgery and for cosmetic
purposes. Founded in 1983, the company is headquartered in West
Cummings Park, Woburn. |
|
|
|
 |
|
Aphios
Corporation |
|
|
Ten
years ago, as a new start-up, Cummings provided Aphios with
the space and the commitment that allowed us to build out
premium biotech space including Biohazard Safety Laboratories
and Good Manufacturing Facilities. Out of this space and commitment,
we have been able to conduct our R&D and are now kicking-off
our next exciting phase of product and technology commercialization.
Trevor
Castor, Ph.D.
President and CEO
|
|
| Aphios
is a biopharmaceutical company that is developing enhanced natural
therapeutics for health maintenance and the treatment of human
diseases with a focus on infectious diseases, cancer and quality-of-life
medicines. |
|
|
|
 |
|
BioTrove,
Inc. |
|
|
Cummings
Properties converted a 20,000 square foot office space to
a top of the line, fully functional biotech facility in just
60 days. It was unbelievable how quickly the construction
was completed. As a result, we experienced no down time as
we moved into 12 Gill Street.
Colin
Brenan, Ph.D.
President and C.E.O.
|
|
| BioTrove
is an early stage biotech company commecializing micro and nanotechnology
for applications in genomics, genetics and drug discovery. The
company moved from Cambridge, MA, where it was founded by five
scientists from the Department of Mechanical Engineering at
M.I.T. |
|
|
|
 |
|
CutisPharma,
Inc. |
|
|
We
were attracted to Cummings Center in Beverly because of reasonable
rent and ample parking it provides compared to typical Boston/Cambridge
leasing properties. Of a particular interest to us was the
guaranteed availability of additional space for expansion.
Indu A.
Muni, Ph.D.
Chairman and CEO
|
|
| CutisPharma
was created to develop and commercialize value-added drug products
and technologies in a niche market within the prescription compounding
sector of the pharmaceutical industry. The companys mission
is to bring innovation to this sector of the industry and create
an area of considerable new value. |
|
|
|
 |
|
CytoCure
LLC |
|
|
Cummings
Center has provided us with everything we need to start research
quickly. Our space was ready in two weeks and we have already
expanded three times in nine months!
Paul Durda
President and CEO
|
|
| CytoCure,
LLC is a cutting-edge biotechnology company dedicated to the
discovery and development of novel immunotherapies for cancer. |
|
|
|
 |
|
ElectroChem |
|
|
We
have housed our operations in a Cummings Properties
facility since ElectroChems inception over a decade
ago because of its proven ability to accommodate any space
or facility need that may arise. I have gotten to know many
Cummings employees at this superb real estate firm and every
interaction has been pleasurable.
Radha
Jalan, Ph.D.
President
|
|
| ElectroChem
Inc. has been a pioneer in Fuel Cell research and Fuel Cell
product development. Founded in 1986, it holds many patents
and a robust list of industry firsts. ElectroChem distinguished
itself by being awarded a contract from NASA to work on its
RLV (reusable launch vehicle) program; as well as maintaining
over 500 customers in more than 70 countries. |
|
|
|
 |
|
GeneXP
Biosciences |
|
|
With
its impressive portfolio of related companies, Cummings Properties
has created a formidable technology campus. Many of our business
partners are within walking distance and we are assured a
place to grow with Cummings unique expansion guarantee.
Michael
Cohen
President
|
|
| GeneXP
Biosciences is a start-up biotech company that delivers end-to-end
solutions for gene expression profiling in high throughput formats.
Unlike current industry formats, GeneXP produces robust tools
and systems that merge Genomics and High Throughput drug screening,
which make fully automated gene expression profiling feasible
and affordable. |
|
|
|
 |
|
Hamilton
Thorne Biosciences,
Inc. |
|
|
The combination of Cummings Properties management, design,
and construction services has allowed us to focus on our research
and not on the building. We know we are in good hands and
look forward to continuing a long relationship with Cummings.
Meg Hamilton
CEO
|
|
| Hamilton
Thorne Biosciences is a DNA technology company, which develops
ultra-high speed, user friendly devices and assays for the healthcare
and environmental markets. The company introduced its first
genetic products in 2002 and the introduction of its signature
mold testing and fungi products is planned for the 4th quarter
of 2003. |
|
|
|
 |
|
Inotek
Pharmaceuticals Corporation |
|
|
Cummings
Properties ability to capitalize a large amount of improvements
into the lease affords start-up companies the ability and
flexibility to use raised capital in other venues such as
personnel.
Andrew L. Salzman, M.D.
President and CEO
|
|
| Inotek
Pharmaceuticals is a multi-national biopharmaceutical firm focused
on discovery research and the development of novel pharmaceutical
technologies with potential applications in critical care, surgery,
trauma, transplantation, and auto-immune diseases. |
|
|
|
 |
|
Lilliputian
Systems,
Inc. |
|
|
As a start-up firm, we needed a small centrally located office
and lab available for immediate occupancy. We also needed
the option of expanding the facility. Very few real estate
firms have all the in-house capabilities to provide this product,
but Cummings Properties Emerging Technology Centers
were a perfect fit.
Aleksander Franz
Founder
|
|
| Lilliputian
Systems, Inc. is developing a next generation micro fuel cell
system for portable electronics and wireless applications. These
fuel cells can provide a significantly longer run time than
traditional batteries and are environmentally friendly. The
company employs a proprietary MEMS-based technology developed
by the founders at the world-class Microsystems Technology Laboratories
at MIT. |
|
|
|
 |
|
Meiogen
Biotechnology Corporation |
|
|
For
a small start-up company like mine, Cummings Properties made
the leasing and build-out process as simple as possible. Its
also nice to know that when my business grows, I have space
options right in my building.
Leonard Maroun
President and CEO
|
|
| Meiogen
is an exceptional start-up biotech company that already has
its first product in development (AntiferonTM) and a patented
method for the treatment of a major disease, Down Syndrome.
AntiferonTM, its novel proprietary interferon inhibitor (patent
pending), is expected to provide the safest and most effective
treatment yet available for large market diseases like Down
Syndrome and AIDS where there is clear evidence that interferon,
a protein our body produces to fight infection, plays an important
causative role. |
|
|
|
 |
|
Nantero,
Inc. |
|
|
Cummings
has a substantial amount of experience working with fast-growing
startups like ours and can rapidly handle our needs, from
space expansion to buildout.
Greg
Schmergel
President and CEO
|
|
| Nantero
is developing NRAM, a high-density, nonvolatile random
access memory chip, using nanotechnology. The companys
objective is to deliver a product that will replace all existing
forms of memory, such as DRAM, SRAM and flash memory, with NRAM
serving as universal memory. |
|
|
|
 |
|
Natural
Pharmaceuticals, Inc. |
|
|
Cummings
Center has attracted a mini-cluster of biotech and pharmaceutical
companies which in turn has attracted a range of professional
services that was very attractive to us.
Roland
R. Franke, Ph.D.
Co-Chief Executive Officer
|
|
| Natural
Pharmaceuticals, Inc. (NPI) produces a dependable supply of
high-purity, semi-synthetic paclitaxel at competitive prices
for the global market. Additionally, NPI provides customers
with technical, regulatory, and analytical support. |
|
|
|
| |
|
OmniSonics
Medical Technologies, Inc. |
|
|
As
we gear up for a U.S. launch of our product, we look forward
to expanding our office and laboratory here with Cummings
Properties. Their management is top-notch, as is the location.
|
|
OmniSonics
Medical Technologies is developing a novel medical device based
on its patented OmniWave Technology platform. The Resolution®
System uses acoustic (or ultrasonic) energy to resolve occlusionsoften
blood clots, plaque or calcific materialswhich occur as
a result of coronary artery disease,
hemodialysis procedures, deep vein thrombosis and peripheral
artery disease. |
|
|
|
 |
|
Predix
Pharmaceuticals, Inc. |
|
|
Cummings
Properties understood that as a start-up pharmaceutical company,
we needed to focus our resources on science to improve peoples
lives, not on the facility. The combination of in-house services
and competitive rates allowed us to reach this goal.
Dr. Michael Kauffman, M.D., Ph.D.
CEO & President
|
|
| Predix
Pharmaceuticals, Inc. is a drug discovery and development company
offering unique value for both todays biotech investor
and tomorrows medical patient. By tightly integrating
our proprietary 3D computational chemistry technologies with
traditional medicinal chemistry, we have created a drug discovery
platform that dramatically accelerates the generation of new
drugs associated with G-protein coupled receptors (GPCRs) and
ion channels. The company will move its first drug into the
clinic in 2004. |
|
|
|
| |
|
Scion
Pharmaceuticals, Inc. |
|
|
It
is a pleasure working with Cummings Properties. Our positive
interaction with their entire staff made it an easy decision
for us to expand our existing facility at 200 Boston Avenue
(in Medford).
|
|
| Scion
Pharmaceuticals applies an innovative drug discovery strategy
that integrates functional biology and chemistry and its discovery
engine is enabled by its proprietary High-Throughput ElectroPhysiology
(HTEP) assay. This approach allows the Company to evaluate
target function and drug activity at the earliest stages of
the discovery process. Scion is initially utilizing this approach
to discover drugs for the treatment of cardiovascular and central
nervous system (CNS) disorders. |
|
|
|
 |
|
Soltec
Ventures, Inc. |
|
|
As
one of Cummings Centers longest residents, I can truly
appreciate the
tremendous restoration of the old factory. This has been reborn
as the research center of the North Shore.
Larry Evans
President
|
|
| Soltec
Ventures is a coalition of experienced bench chemists providing
the advanced custom synthesis and specialty biochemical compound
manufacture that researchers require. Their expertise is centered
in proteomics, combinatorial chemistry, clinical diagnostics,
and pharmaceutical intermediates. |
|
|
|
 |
|
VisEn
Medical, Inc. |
|
|
In
working with Cummings Properties management team, we were
able to complete our design built facility within the expected
timelines. We are extremely pleased with the results they
delivered.
Guy Mayer
CEO and Chairman of the Board
|
|
| Founded
in June of 2000, VisEns core technology platforms were
originally developed at the Massachusetts General Hospital and
Harvard Medical School. VisEn aggressively pursues key industry
alliances to deepen and broaden its technology base and intellectual
property platforms both internally and through additional corporate
and academic licensing programs. VisEn is dedicated to developing
and protecting leading technologies in molecular imaging, and
launching key molecular imaging products with maximum market
potential. |
|
|
|
| All of the above testimonials have been excerpted
from approved promotional advertisements which have typically appeared
in The Boston Globe, Boston Business Journal, and New England Real
Estate Journal. Cummings Properties is pleased to support some of
its many many life-science firms in this way, and is very appreciative
of their many complimentary testimonials concerning their experiences
with this firm. |
|
|
|
Арендуйте
офис в Соединенных
Штатах Америки.
Арендуйте
американский
офис. Снимите
в аренду помещение
под офис или
лабораторию
в Бостоне, Mассачусeттс,
США. Коммерческие
помещения
расположены
в Бостоне и
Кембридже,
MA, США. Помещения
под офис, научно-исследовательскую
лабораторию,
а также коммерческое
пространство
для продажи
или в аренду
по низким ценам
находятся
возле Международного
Аэропорта
Logаn, в Бостоне,
MA, США. Звоните
Джону Вайсману
по телефону
001-781-932-7040.
Предлагаются
800 тыс. квадратных
метров новых
современных
офисов, научно-исследовательских
лабораторий
и другого коммерческого
пространства.
Арендуйте
помещение
любого размера
сегодня. Cummings Properties,
200 West Cummings Park, Woburn, MA 01801, USA.
|
|
| |
| Intentional
spelling and typographical errors
Common "typographical"
errors will include Commings [sic], Commins [sic] or Cummins [sic] Property
[sic] and Propeties [sic], as well as using "WoburnMA," "CambridgeMA,"
"BeverlyMA" and "BostonMA." Others include running
words together as in: "rentspace," "leasespace," "realestate,"
"officespace," "rentspace," "leaselaboratory,"
"leaseoffice," "findspace," "commercialproperty
for lease," "leaselab space," "findoffice space,"
"lease officespace," "rentoffice space," "rent
officespace," etc.
Cummins Property
leases officespace, labspace and other comercial realestate in BostonMA,
CambridgeMA, WoburnMA, and BeverlyMA. Rentspace in Boston and Cambridge
areas for clinical offices, research, laboratories, etc. Commins Properties,
leases lab and research space. Biology and chemistry labs available, as
well as office, storage and distribution facilities. Call Cummings Property
at 781-935-8000.
These typographical
errors were added to make it easier for users to reach our Cummings Properties
site even if they accidentally misspell our name or comments.
|
| |
|
Facilities
for NIH Research
Some
people describe Cummings Properties as the best commercial real estate
firm in New England. The firm offers fully permitted biotech buildings
with existing Class 100,000, Class 10,000 and, sometimes, Class 1,000
clean rooms in MA, as well as fully permitted chemistry and biology laboratories
in the Cambridge area for lease, with hazardous waste management in place.
Lease quiet, Feng Shui-designed facilities for short or longer term critical
trials in Massachusetts, and also for genetic biology, stem cell research
and NIH work. Abundant free parking in all locations.
Lease
Cambridge-area, turnkey labs for clinical research projects of National
Human Genome Research Institute and other short or long-term grants
funded by National Institutes of Health in MA. Boston area incubator
facilities also for studies for National Eye Institute, National
Institute on Aging, and the National Heart, Lung and Blood Institute.
Boston-area facilities are also offered for National Gene Vector Laboratories,
as well as for Islet Cell Research (ICR) and general genetic biology needs.
Cummings Properties supports veterinary medical care through its long-term
backing of Cummings School of Veterinary Medicine at Tufts University.
Lease
easily expanded science and technology space in Cambridge, with dual redundant
building systems. Technopoles for advanced technology in MA. Lease lab
modules in Boston incubator building for technology innovations. Lease
fully validated Massachusetts research space with emergency generators
and 100 percent outside air. Large fully permitted Class 100K cleanroom,
and smaller Class 10K, available for lease at Cummings Center in Beverly,
MA. Ideal for pharmaceutical and medical device industries, built by Medtronic
in 2000. Sub-lease nanotechnology space near Tufts and MIT at low rate.
|
| |
|
|
| |
|
|
| |
| |